Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma
Avivi, Irit, Balaban, Roi, Shragai, Tamir, Sheffer, Gabi, Morales, Miguel, Aharon, Anat, Lowenton‐Spier, Noa, Trestman, Svetlana, Perry, Chava, Benyamini, Noam, Mittelman, Moshe, Tabib, Yaara, Bar Lev, Tali, Zavaro, Mor, Herishanu, Yair, Luttwak, Efrat, Cohen, Yael C.
Published in British Journal of Haematology (01.10.2021)
Published in British Journal of Haematology (01.10.2021)
Get full text
Journal Article
Web Resource
A Phase II Multicenter Clinical Trial Assessing the Safety and Efficacy of Ixazomib, Pomalidomide and Dexamethasone Combination As Second or Third-Line Treatment for Triple-Class Exposed Patients with Relapsed and Refractory Multiple Myeloma (iPod-790 Trial)
Cohen, Yael C., Shragai, Tamir, Lavi, Noa, Vaxman, Iuliana, Chubar, Evgeni, Gatt, Moshe E, Ganzel, Chezi, Magen, Hila, Luttwak, Efrat, Mittelman, Moshe, Tzoran, Inna, Vainstein, Vladimir, Lowenton-Spier, Noa, Melamed, Natan, Krayzler, Ella, Pereg, Ilana, Avivi Mazza, Irit
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Phase II Multicenter Clinical Trial Assessing the Safety and Efficacy of Ixazomib Pomalidomide Dexamethasone Combination As Second or Third-Line Treatment for Patients with Triple Exposed Relapsed and Refractory Multiple Myeloma: Prespecified Interim Analysis (IPoD-790 trial)
Cohen, Yael C, Shragai, Tamir, Lavi, Noa, Vaxman, Iuliana, Chubar, Evgeni, Gatt, Moshe E, Ganzel, Chezi, Magen, Hila, Luttwak, Efrat, Lowenton-Spier, Noa, Gez-Aaronson, Liron, Melamed, Natan, Avivi, Irit
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
Cloughesy, Timothy F, Brenner, Andrew, de Groot, John F, Butowski, Nicholas A, Zach, Leor, Campian, Jian L, Ellingson, Benjamin M, Freedman, Laurence S, Cohen, Yael C, Lowenton-Spier, Noa, Rachmilewitz Minei, Tamar, Fain Shmueli, Shifra, Wen, Patrick Y
Published in Neuro-oncology (Charlottesville, Va.) (15.05.2020)
Published in Neuro-oncology (Charlottesville, Va.) (15.05.2020)
Get full text
Journal Article
Daratumumab Carfilzomib Lenalidomide Dexamethasone Provides Effective Salvage for Functionally and Cytogenetically High-Risk Myeloma Patients, Except Those Expressing Module-1 Transcriptional Signature: Extended Follow-up from Kydar Multicenter Clinical/Translational Trial
Cohen, Yael C, Gatt, Moshe E, Luttwak, Efrat, Lavi, Noa, Ganzel, Chezi, Chubar, Evgeni, Rouvio, Ory, Vaxman, Iuliana, Pasvolsky, Oren, Ballan, Mouna, Tadmor, Tamar, Nemets, Anatoly, Jarchowsky, Osnat, Shvetz, Olga, Shpilberg, Ofer, Dally, Najib, Leiba, Merav, Weiner, Assaf, Zada, Mor, Wang, Shuang-Yin, Gur, Chamutal, Lowenton-Spier, Noa, Goor-Porges, Liron, Amit, Ido, Avivi, Irit
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
ATIM-19. RESULTS OF THE GLOBE STUDY: A PHASE 3, RANDOMIZED, CONTROLLED, DOUBLE-ARM, OPEN-LABEL, MULTI-CENTER STUDY OF VB-111 COMBINED WITH BEVACIZUMAB VS. BEVACIZUMAB MONOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA
Cloughesy, Timothy, Brenner, Andrew J, Butowski, Nicholas, Cohen, Yael C, Lowenton-Spier, Noa, Wen, Patrick
Published in Neuro-oncology (Charlottesville, Va.) (05.11.2018)
Published in Neuro-oncology (Charlottesville, Va.) (05.11.2018)
Get full text
Journal Article
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study
Brenner, Andrew J, Peters, Katherine B, Vredenburgh, James, Bokstein, Felix, Blumenthal, Deborah T, Yust-Katz, Shlomit, Peretz, Idit, Oberman, Bernice, Freedman, Laurence S, Ellingson, Benjamin M, Cloughesy, Timothy F, Sher, Naamit, Cohen, Yael C, Lowenton-Spier, Noa, Rachmilewitz Minei, Tamar, Yakov, Niva, Mendel, Itzhak, Breitbart, Eyal, Wen, Patrick Y
Published in Neuro-oncology (Charlottesville, Va.) (15.05.2020)
Published in Neuro-oncology (Charlottesville, Va.) (15.05.2020)
Get full text
Journal Article
Clinical trial in progress: A study of VB-111 combined with paclitaxel vs. paclitaxel for treatment of recurrent platinum-resistant ovarian cancer (OVAL, VB-111-701/GOG-3018)
Penson, Richard T., Moore, Kathleen N., Herzog, Thomas J., Burger, Robert Allen, Freedman, Laurence S, Lowenton-Spier, Noa, Harats, Dror, Sher, Naamit, Cohen, Yael Chava, Monk, Bradley J.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
NIMG-17. VALIDATION OF DIFFUSION MRI AS AN IMAGING BIOMARKER FOR BEVACIZUMAB THERAPY IN RECURRENT GLIOBLASTOMA IN A RANDOMIZED PHASE III TRIAL OF BEVACIZUMAB WITH OR WITHOUT VB-111 (GLOBE)
Ellingson, Benjamin, Cloughesy, Timothy, Wang, Chencai, Patel, Kunal, Raymond, Catalina, Brenner, Andrew, de Groot, John, Butowski, Nicholas, Zach, Leor, Campian, Jian, Schlossman, Jacob, Rizvi, Shan, Cohen, Yael, Lowenton-Spier, Noa, Minei, Tamar Rachmilewitz, Fain-Shmueli, Shifra, Wen, Patrick
Published in Neuro-oncology (Charlottesville, Va.) (09.11.2020)
Published in Neuro-oncology (Charlottesville, Va.) (09.11.2020)
Get full text
Journal Article
Treatment through progression with ofranogene obadenovec (VB-111), an anti-cancer viral therapy, significantly attenuates tumor growth in recurrent GBM: Individual phase 2 patient data
Brenner, Andrew Jacob, Wen, Patrick Y., Vredenburgh, James J., Peters, Katherine B., Blumenthal, Deborah T., Freedman, Laurence S, Oberman, Bernice, Lowenton-Spier, Noa, Lavi, Michal, Harats, Dror, Cohen, Yael Chava
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastoma
Ellingson, Benjamin M, Patel, Kunal, Wang, Chencai, Raymond, Catalina, Brenner, Andrew, de Groot, John F, Butowski, Nicholas A, Zach, Leor, Campian, Jian L, Schlossman, Jacob, Rizvi, Shan, Cohen, Yael C, Lowenton-Spier, Noa, Minei, Tamar Rachmilewitz, Shmueli, Shifra Fain, Wen, Patrick Y, Cloughesy, Timothy F
Published in Neuro-oncology advances (01.01.2021)
Published in Neuro-oncology advances (01.01.2021)
Get full text
Journal Article